Common Chemicals Damage Sperm

Researchers elucidate a molecular mechanism through which endocrine disrupting compounds compromise the viability of human gametes.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIAAdditives known as endocrine disrupting chemicals (EDCs) compromise male fertility by interfering with a membrane-bound calcium channel that normally controls motility of sperm cells, according to researchers in Germany and Denmark. EDCs are used in hundreds of household products—including toothpastes, sunscreens, cosmetics, plastic bottles, and toys—and scientists determined that they can cause fertility problems in previous studies. But a study published in the journal EMBO reports yesterday (May 12) is the first to posit a mechanism for how the chemical additives affect fertility in the human reproductive tract.

“For the first time, we have shown a direct link between exposure to endocrine disrupting chemicals from industrial products and adverse effects on human sperm function,” study coauthor and Copenhagen University Hospital researcher Niels Skakkebaek said in a statement.

Skakkebaek and his colleagues tested 96 EDCs and found that about a third of them disrupted the function of an ion channel, called CatSper, in the membranes of sperm cells in vitro. EDCs, at concentrations typical for bodily fluids, added to human sperm opened CatSper channels, causing calcium to rush into the cells. This increased concentration of calcium ions changed the swimming behavior of the sperm, triggering the premature release of digestive enzymes that sperm need to breach the outer layers of egg cells. EDCs also ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies